Index of artpub/2022/275176/

Álvarez Larrán, Alberto
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea
2022
https://ddd.uab.cat/record/275176